Quinazoline modulators of hepatocyte growth factor / c-Met activity for the treatment of cancer

Details for Australian Patent Application No. 2005269974 (hide)

Owner Angion Biomedica Corporation

Inventors Zembower, David E.; Mishra, Rama; Sing, Jasbir

Agent Shelston IP

Pub. Number AU-A-2005269974

PCT Pub. Number WO2006/014420

Priority 60/585,734 06.07.04 US

Filing date 6 July 2005

Wipo publication date 9 February 2006

International Classifications

C07D 239/95 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/505 (2006.01) - Pyrimidines

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

1 March 2007 PCT application entered the National Phase

  PCT publication WO2006/014420 Priority application(s): WO2006/014420

23 July 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005269978-Methods and compositions for detecting and isolating phosphorylated molecules using hydrated metal oxides

2005269973-Method and system for improved short message services